References
Newburger JW, Takahashi M, Gerber MA, et al; Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease; Council on Cardiovascular Disease in the Young; American Heart Association; American Academy of Pediatrics. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004;110:2747–71.
Minich LL, Sleeper LA, Atz AM, et al; for the Pediatric Heart Network Investigators. Delayed diagnosis of Kawasaki disease: what are the risk factors? Pediatrics. 2007;120:1434–40.
Moreno N, Méndez-Echevarría A, de Inocencio J, et al. Coronary involvement in infants with Kawasaki disease treated with intravenous gamma-globulin. Pediatr Cardiol. 2008;29:31–5.
Kobayashi T, Inoue Y, Takeuchi K, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation. 2006;113:2606–12.
Burns JC, Capparelli EV, Brown JA, Newburger JW, Glode MP. Intravenous gamma-globulin treatment and retreatment in Kawasaki disease US/Canadian Kawasaki Syndrome Study Group. Pediatr Infect Dis J. 1998;17:1144–8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Puri, V., Kanitkar, M. Atypical Kawasaki Disease. Indian J Pediatr 80, 267–268 (2013). https://doi.org/10.1007/s12098-012-0769-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-012-0769-x